Skip to main content

Inside the development of cell and gene therapies

More than 25 cell and gene therapy products have been approved by the FDA, and this burgeoning class of treatments is experiencing its own explosive growth. As more of these potentially curative therapies reach patients, the industry continues to experiment with solutions to grapple with growing pains.

included in this trendline
  • For Duchenne-focused Sarepta, gene therapy is the natural next step
  • Gracell Biotechnologies’ quest to unlock the CAR-T bottleneck
  • While CAR-T wait times remain ‘heartbreaking,’ researchers push for innovations that could help
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.